AUSTIN, Texas, Oct. 12, 2015 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX) today announced that it expects to
report results for the third quarter ended September 30, 2015 on Monday, November 2, 2015. A press release
announcing the results is scheduled for release after the close of
trading.
Management will hold a conference call to discuss the operating
highlights and financial results for the third quarter ended
September 30, 2015 on November 2, 2015, at 4:30
p.m. Eastern time.
The conference call will be webcast live and may be accessed at
Luminex Corporation's website at http://www.luminexcorp.com. Simply
log on to the website, go to the About Us section and access the
Investor Relations link. Please go to the website at least 15
minutes prior to the call to register, download and install any
necessary audio/video software. If you are unable to participate
during the live webcast, the call will be archived for six months
on the website using the 'replay' link.
The use of pop-up blocking software may impair your ability to
view webcasts. If you use this software, press and hold the CTRL
key when you click on the Register button. Please contact your IT
group if you are unable to override this feature. Unauthorized
recording or downloading of this event is not permitted.
About Luminex Corporation
Luminex is committed to applying its passion for innovation
toward advancing healthcare and research worldwide. The Company is
transforming global healthcare and life-science research through
the development, manufacturing and marketing of proprietary
instruments and assays utilizing xMAP®
open-architecture, multi-analyte platform and MultiCode®
real-time polymerase chain reaction (PCR) and multiplex PCR-based
technologies, that deliver cost-effective and rapid results to
clinicians and researchers. Luminex's technology is commercially
available worldwide and in use in leading clinical laboratories as
well as major pharmaceutical, diagnostic, biotechnology and
life-science companies. The Company is meeting the needs of
customers in markets as diverse as clinical diagnostics,
pharmaceutical drug discovery, biomedical research including
genomic and proteomic research, personalized medicine, bio-defense
research and food safety. For further information on Luminex
Corporation and the latest advances in multiplexing using award
winning technology, please visit http://www.luminexcorp.com.
Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com
Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com
Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/luminex-corporation-third-quarter-earnings-release-scheduled-for-november-2-2015-300158027.html
SOURCE Luminex Corporation